EA
BSX icon

Emerald Acquisition’s Boston Scientific BSX Stock Holding History

Emerald Acquisition’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$29M Buy
1,218,446
+399,432
+49% +$9.53M 0.06% 399
2016
Q2 		$19.1M Buy
+819,014
New +$17.7M 0.03% 612

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Emerald Acquisition's BSX Position: Q3 2016 in Review

Emerald Acquisition increased its Boston Scientific (BSX) stake by 49% in Q3 2016, buying an estimated $9.53M and bringing the position to 1,218,446 shares worth $29M. The position accounts for 0.06% of the portfolio, ranked #399.

Emerald Acquisition first reported a position in BSX in Q2 2016 and has held it in 2 quarters since. 565 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Emerald Acquisition held 1,218,446 shares of Boston Scientific worth $29M as of Q3 2016.
  • Emerald Acquisition bought 399,432 Boston Scientific shares in Q3 2016, an estimated $9.53M.
  • Boston Scientific made up 0.06% of Emerald Acquisition's portfolio in Q3 2016, its #399 holding.
  • Emerald Acquisition first reported a position in Boston Scientific in Q2 2016 and has held it in 2 quarters since.
  • 565 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.